COVID-19

Latest News

People walking with masks | Image credit: blvdone - stock.adobe.com

5 Things to Know About COVID-19 Before the Holiday Season

By Julia Bonavitacola

December 13th 2024

As the holidays approach, experts recommend tips to reduce the risk of COVID-19.

COVID-19 vaccine | Image credit: Leigh Prather - stock.adobe.com

Pfizer COVID-19 Vaccine Effective in Children Aged 5 to 17 Years

By Julia Bonavitacola

December 12th 2024

Fluvoxamine for COVID-19. | Image credit: pureradiancecmp - stock.adobe.com

Fluvoxamine Fails to Shorten COVID-19 Symptom Duration in Mild to Moderate Outpatients

By Pearl Steinzor

December 8th 2024

Cardiomyopathy. | Image Credit: TechTonic - stock.adobe.com

COVID-19 Infection Increases Risk of Severe Outcomes in Patients With Certain Cardiomyopathies

By Cameron Santoro

December 5th 2024

Nasal swab for COVID-19 | Image Credit: © BASILICOSTUDIO STOCK - stock.adobe.com

Nasal Swab Test Can Predict COVID-19 Severity Through Autoantibody Analysis

By Luke Halpern

November 26th 2024

Continuing Medical Education

View All

December 13th 2024

Navigating the HIV Treatment Frontier: Equipping Managed Care Professionals With Strategies for Innovation, Access, and Adherence

1.5 Credits / HIV/AIDS, Infectious Diseases

More News

June 7th 2023

How Do Primary Hospitals Enact Early Response to the Relaxation of COVID-19 Prevention and Control Measures? The Experience From Chengdu, China

Yuwei Kang, MB Junjie Mou, MM Bo Lv, PhD Ping Liu, MB Yuting Fu, MB Wei Yang, MB Wei Zhou, MB Shijie Ma, MB Sheng Xiao, MB Run Wang, MB Fei Deng, MM

This article examines how primary hospitals in Chengdu, China, responded to the relaxation of COVID-19 prevention and control measures in December 2022.

June 6th 2023

COVID-19 Vaccine Hesitancy and Health Literacy in US Southern States

Hadii M. Mamudu, PhD, MPA Manik Ahuja, PhD Esther Adeniran, DrPH Adekunle Oke, MD, DrPH Bridget Hamilton, MPH KariLynn Dowling-McClay, PharmD, MPH Rebecca A. Fletcher, PhD David W. Stewart, PharmD JoAnne Collins, MPH Janet Keener, EdD Timir K. Paul, MD, PhD Florence M. Weierbach, PhD, MPH, RN

COVID-19 vaccine hesitancy is not associated with health literacy. Personal perception of threat was associated with reduced vaccine hesitancy.

May 26th 2023

What We’re Reading: COVID-19 Drug Approval; Thousands Lost Medicaid Coverage; Menstrual Cycles and CVD Risk

AJMC Staff

The FDA approves Pfizer’s oral COVID-19 drug; hundreds of thousands of people lose Medicaid coverage after pandemic protections expire; irregular menstrual cycles seem to be linked with higher cardiovascular disease (CVD) risks.

Microscopic close-up of the covid-19 disease. Coronavirus illness spreading in body cell. 2019-nCoV analysis on microscope level 3D rendering: © sdecoret - stock.adobe.com

April 23rd 2023

Review Identifies Factors Linked With COVID-19 Discharge to Postacute Care Facilities

Gianna Melillo

Older age, more comorbidities, and having higher baseline inflammatory markers were among these factors.

woman scientist holding a coronavirus in a research lab: © Paulista - stock.adobe.com

April 18th 2023

Most COVID-19 RCT Abstracts Posted to medRxiv Published After 1 Year

Gianna Melillo

Preprints, or research that is not peer reviewed, are becoming increasingly important in medical communication for findings of randomized clinical trials (RCTs).

Adult and child holding kidney , world kidney day, kidney stone, Nephrology , organ donation concept: © SewcreamStudio - stock.adobe.com

April 16th 2023

Review Probes Intricacies of Protecting Kidney Transplant Recipients From COVID-19

Jared Kaltwasser

Vaccines were safe in transplant recipients, but their efficacy was affected by immunosuppressive therapies.

April 12th 2023

Limited English Proficiency, Other Language Preference Associated With Increased COVID-19 Hospitalization Rates

Julia Bonavitacola

Patients who had limited proficiency with English or preferred the use of another language had increased hospitalization and death rates if they delayed time to their first dose of the vaccine.

Silhouette of troubled person head: © tadamichi - stock.adobe.com

April 10th 2023

Anxiety, Depression, Suicidal Ideation Common Among College Students at Start of COVID-19 Pandemic

Jared Kaltwasser

The study was designed and conducted by undergraduate researchers.

March 22nd 2023

Kashyap Patel, MD, Sees Link Between COVID-19 and Cancer Progression, Calls for More Biomarker Testing

Hayden E. Klein

Recent papers highlight possible role of inflammation in connections between COVID-19, cancer markers.

February 21st 2023

Spotlights From Our Cochairs: Kashyap Patel, MD, Talks Value-Based Care, Effects of COVID-19 on Cancer Care Delivery

Hayden E. Klein

February 15th 2023

Population Health Strategies to Advance Health Equity: A Q&A With Dr Paul G. Alexander

Matthew Gavidia Paul G. Alexander, MD, MPH

Paul G. Alexander, MD, MPH, executive vice president and chief health equity and transformation officer, RWJBarnabas Health, speaks on strategies his organization implemented during the COVID-19 pandemic to address continuity of care and communication challenges in underserved communities and further efforts to improve health equity.

February 5th 2023

ASH 2022: COVID-19

Hayden E. Klein

Coverage from the 64th Annual American Society of Hematology Meeting and Exposition, December 10-13, 2022, New Orleans, Louisiana.

January 31st 2023

Biden to End COVID-19 National Emergencies in May

Allison Inserro

The Biden administration has said it would give 60 days notice before ending the public health emergency, which was set to end April 11, and the national emergency was set to end March 1.

January 26th 2023

What We’re Reading: Affordable Care Act Update; COVID-19 Booster Effectiveness; Lawsuit Disputes Abortion Pill Ban

AJMC Staff

Affordable Care Act health care sign-ups are breaking records; updated COVID-19 boosters are proving successful against new variants; GenBioPro, which manufactures mifepristone, has filed suit regarding the constitutionality of a state abortion drug ban.

January 17th 2023

Paxlovid May Reduce Already Low Risk of COVID-19 Hospitalization, Death Among Vaccinated Patients

Jaime Rosenberg

Patients who received nirmatrelvir plus ritonavir (Paxlovid) had lower risk of both hospitalization within 14 days and death within 28 days compared with patients who did not receive the treatment.

January 17th 2023

15 Things About the Diagnosis, Management, and Treatment of Long COVID

Allison Inserro

The most common symptoms of long COVID include fatigue, anxiety and depression, shortness of breath, sleep disturbances, and heart palpitations.

January 14th 2023

Prioritize Paxlovid for Unvaccinated Patients at High Risk of Severe COVID-19: Cost-effectiveness Analysis

Jaime Rosenberg

A new analysis has determined the cost-effectiveness of nirmatrelvir/ritonavir (Paxlovid), granted emergency use authorization by the FDA, across various scenarios of vaccination status and risk for severe disease.

January 12th 2023

Political Stance Does Not Overturn People’s Real-Life Perceptions on COVID-19, Study Finds

Pearl Steinzor

A study found evidence to suggest that political opinion does not significantly shape people’s perceptions of the COVID-19 pandemic from a local standpoint.

January 12th 2023

What We're Reading: NYC Nursing Strike Ends; Hospital Volunteers and Labor Laws; Most Long COVID Symptoms Ease

AJMC Staff

Nurses in New York City reach agreement and end strike; hospitals benefiting from volunteer staff may be breaking labor laws; most lingering COVID symptoms will heal on its own, study finds.

January 10th 2023

What We’re Reading: Biden to Extend PHE Once More; High Court Rejects Pharma Suits; 988 Calls Soar

AJMC Staff

President Joe Biden expected to renew COVID-19 public health emergency (PHE) one more time; Bristol Myers Squibb and Pfizer are denied by the Supreme Court; funding for the 988 mental health helpline expands inclusivity efforts.

January 6th 2023

What We’re Reading: SC, ID Courts Rule on Abortion; NIH Pilots COVID-19 Program; ADHD Drug Shortages Rise

AJMC Staff

State courts in South Carolina and Idaho ruled in opposite ways on abortion bans; virtual COVID-19 diagnostic and treatment launches in community; generic methylphenidate medication shortages negatively impact ADHD treatment.

December 22nd 2022

Top 5 Most-Read COVID-19 News of 2022

AJMC Staff

2022's most-read news about the pandemic included the impact of COVID-19 on patients with asthma, the Biden administration's plans to advance vaccination and other initiatives, information about when SARS-CoV-2 is at its most infectious, and more.

December 14th 2022

Impact of COVID-19 Seen in 2021 National Health Care Expenditures Report

Allison Inserro

The effects of the COVID-19 pandemic were clear in the US national health care expenditure analysis of spending last year, as federal spending dropped, but health care use rebounded in 2021.

December 8th 2022

What We’re Reading: ACA Marketplace Enrollment Rises; Vaccine Sharing Initiative May End; Tracking Opioid Overdoses

AJMC Staff

Approximately 5.5 million people have enrolled in health care coverage through the Affordable Care Act (ACA) marketplace for 2023; the Gavi alliance is debating the end of the worldwide vaccine sharing initiative; the White House is now tracking nonfatal opioid overdoses.

December 6th 2022

Contributor: COVID-19 Fell in Rank Among Telehealth Diagnoses Nationally in September 2022

Robin Gelburd, JD

According to the most recent data from FAIR Health, COVID-19 telehealth diagnoses declined in 3 of the 4 census regions in the United States.

November 26th 2022

Nirmatrelvir-Ritonavir Highly Effective at Preventing COVID-19 Hospitalization, RWE Says

Jared Kaltwasser

The study of real-world evidence (RWE) found nearly 9 in 10 patients in a highly vaccinated cohort avoided hospitalization within 15 days of treatment for COVID-19.

November 23rd 2022

Nirmatrelvir-Ritonavir Shows Safety, Efficacy in Real-world Study of High-risk COVID-19 Patients

Rose McNulty

The retrospective study evaluated outcomes in patients prescribed nirmatrelvir-ritonavir, as well as the management of drug interactions by clinical pharmacists prescribing the regimen.

November 19th 2022

Researchers Point to IL-26 as Biomarker of Severe COVID-19

AJMC Staff

High levels of interleukin (IL)-26 levels correlate with an exaggerated inflammatory response that signifies severe cases of the disease, according to researchers.

November 11th 2022

Contributor: COVID-19 Fell in Rank Among Telehealth Diagnoses in South and West in August 2022

Robin Gelburd, JD

Telehealth diagnoses in the South and West regions of the United States saw a reduction in COVID-19 diagnoses.

November 10th 2022

What We’re Reading: Listeria Outbreak; COVID-19 Death Decline; Eli Lilly Pays in Drug Patent Trial

Julia Bonavitacola

A listeria outbreak has been linked to deli meats and cheeses; the World Health Organization announced that there has been a 90% drop in recent deaths in COVID-19 globally compared with 9 months ago; Eli Lilly was ordered to pay $176.5 million in a US migraine drug patent trial.

<1 2 3 >

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions